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Abstract
Background: Goblet cell carcinoid is a rare variant of appendiceal carcinoid with mixed endocrine and exocrine features.
The most common symptom and signs are abdominal pain, acute appendicitis and palpable mass. Additionally, abdominal
pain is common in patient on peritoneal dialysis, which may confound the diagnosis in such patient.
Case presentation:We report a 71- years- old woman on peritoneal dialysis that experienced several episodes of
abdominal cramping pain and sterile peritonitis. She had one episode of severe pain and underwent an appendectomy for
suspicion of appendicitis. Goblet cell carcinoid was diagnosed. She had no further abdominal pain after she received
appendectomy.
Conclusions: Malignant dialysate was rarely reported in patient with peritoneal dialysis. However, goblet cell carcinoid can
initially present with acute appendicitis, chronic intermittent abdominal pain and mimicking peritonitis. In systemically
reviewing the literature, this is the first case report of sterile peritonitis with peritoneal dialysis caused by goblet cell
carcinoid.
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Background
Goblet cell carcinoid is a rare variant of appendiceal
carcinoid with mixed endocrine and exocrine features.
The most common clinical presentation is acute appen-
dicitis [1, 2]. Typically, GCC tumors are infiltrative and
involve the entire appendix circumferentially [3]. Never-
theless, Tang et al. [1] reported that abdominal pain and
palpable mass are also reported presented in 50% of
GCC patients. Additionally, abdominal pain is common
in patients on peritoneal dialysis, which may confound
the diagnosis in such patient. For these patients, right
hemicolectomy has been traditionally suggested by
physician [2]. We performed systematic review of
PubMed and Cochrane Library databases and noted no
similar cases of goblet cell carcinoid causing abdominal
pain which mimics peritoneal dialysis related peritonitis.
We report this unique case of GCC presenting with ster-
ile peritonitis in a patient on peritoneal dialysis to
prompt clinicians to consider GCC in the differential
diagnosis of similar symptoms in such patients.
Case presentation
A 71- years- old woman with underlying hypertension
and end- stage renal disease on peritoneal dialysis, expe-
rienced several episodes of abdominal cramping pain
with mild diarrhea 3 months after starting peritoneal
dialysis. She had chills but no fever. A physical examin-
ation showed lower abdominal tenderness, but no
rebounding pain. Initial complete blood count showed
no leukocytosis (8400/μL). However, the initial dialysate
studies showed increasing leukocytes with a predomin-
ance of neutrophils in first few sample, shifting to
lymphocyte predominance in later sample (Table 1). Di-
alysate and blood cultures from 15 sets over 4 months
since initial abdominal pain showed no growth. Since
empirical antibiotic treatment did not improve the pa-
tient’s condition of recurrent cramping pain, abdominal
computerized tomography (CT) was performed which
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revealed no abnormality. The patient still complained
intermittent abdominal pain after the CT, so pain con-
trol medication (including acetaminophen and tramadol)
was prescribed for the patient. The Tenckhoff catheter
was removed 2 months after the onset of abdominal
pain, and then hemodialysis was started. Laparotomy
and biopsy of peritoneal were performed during removal
of Tenckoff catheter. Staining for acid-fast bacilli was
negative. She continued to complain of intermittent
abdominal cramping pain. One and half year after her
initial abdominal pain, abdominal CT was again per-
formed due to an episode of particularly severe abdom-
inal pain. The scan showed fluid collection in the right
pelvic cavity extending to the distal part of the appendix
(Fig. 1). An appendectomy was immediately performed,
and goblet cell carcinoid (GCC) with suppurative appen-
dicitis was diagnosed. The CT scan before patient re-
ceived appendectomy show the swollen appendix
without obvious extraappendiceal lesion. On the other
hand, according to the surgical and histopathological
findings, the appendix was perforated with adhesion to
ileum, accompanied by regional inflammatory changes
in pelvic cavity. Microscopically, the infiltrating neoplas-
tic cells were found in the appendiceal wall, including
mucosa, submucosal, muscular propria, and subserosal
layers. The infiltrated wall also showed fibrotic change.
No evidence extra-appendiceal invasion of the tumor
could be found (Fig. 2, the pathology specimen of this
patient). Right hemicolectomy and adjuvant chemother-
apy were suggested for complete treatment of GCC but
the suggestions were refused by the patient. No further
abdominal pain has been noted since appendectomy,
and the patient still visits oncologist outpatient depart-
ment for regular follow up without evident of recurrent
tumor.
Discussion and Conclusions
Peritonitis in during peritoneal dialysis is a significant
complication in clinically which can cause death or
structural changes of the peritoneum [4]. Peritoneal in-
fection is also a common cause of dialysis patients
switching the therapy from peritoneal dialysis to
hemodialysis [5]. On the other hand, sterile peritonitis is
a common issue in the patients receiving peritoneal
dialysis. Sterile peritonitis, culture-negative peritonitis, is
often caused by antecedent empirical antibiotic treat-
ment before dialysate culture are collected for culture.
Additionally, infection caused by atypical organisms or
non-infectious causes, can also lead to sterile peritonitis
[6]. Peritoneal dialysate cultures prove to be negative in
up to 22% of case [6]. Patients using icodextrin for
peritoneal dialysis often develop peritonitis with an
associated non-neutrophil predominant increasing in
dialysate white blood cells [7]. Tuberculous (TB) peri-
tonitis and malignancy related peritonitis also cause
similar changes [6]. However, non-neutrophil-dominant
increases in dialysate white blood cells in association
with malignancy dialysate are rare [8, 9]. Lymphoma
sometimes mimics peritonitis in patients on ambulatory
peritoneal dialysis [8]. Peritoneal metastases can also
mimic peritonitis [9].
Goblet cell carcinoid (GCC), an unique and enigmatic
tumor involving the appendix almost exclusively, is a
rare variant of appendiceal carcinoid [10]. Carcinoid tu-
mors account for up to 85% of all appendiceal tumors,
white, GCC accounts for only 6% of all appendiceal
Table 1 Serial dialysate analysis of patient during episodes of abdominal pain in 2012
Date 09/13 09/16 09/19 09/21 09/25 10/02 10/12 11/19
Specific gravity 1.010 1.018 1.010 1.010 1.014 1.014 1.010 1.010
Red blood cells/mm3 6 180 63 297 126 81 75 9
White blood cells/mm3 136 648 243 90 144 222 252 494
Neutrophil:Lymphocyte:H:M 24:21:48:2:5(E) 80:20 48:16:28:8 24:27:48:1 35:32:22:4:7 10:81:1:8(E) 4:92:4 44:53:1:2
H macrophage, M mesothelial, E Eosinophil
Fig. 1 Contrast-enhanced pelvic computed tomography. The scan
reveals one 2.1 × 1.6 cm irregular-shaped cystic mass (arrow) with
marginal enhancement in the right pelvic cavity, abutting the swollen
appendix (arrowhead). The tumor is located at the tip of appendix with
possible subserosa invasion and attaches to the right pelvic side wall.
The scan also shows inflammatory change with regional ileal bowel
loop adhesion to the mass. Some fluid collection around the tumor-
bowel complex is noted
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carcinoid tumors [11]. The term GCC was firstly intro-
duced by Subbuswamy et al. in 1974 [12]. GCC derive from
a pluripotent intestinal stem cell that differentiates into both
mucinous and neuroendocrine cells [13]. Thus, it shares
histologic features of both adenocarcinomas and carcinoid
tumors. Additionally, GCC is reportedly more aggressive
and unpredictable in nature than other carcinoid tumors.
The most common clinical presentation is acute ap-
pendicitis [1]. Abdominal pain and a palpable mass are
also reported by 50% of GCC patients [2]. Pham et al.
[1]. also reported other symptoms including bowel ob-
struction, intussusception, gastrointestinal bleeding, and
chronic intermittent lower abdominal pain. Compared
with other carcinoid tumors which are usually asymp-
tomatic, GCC often presents with clinical symptoms.
Thus, the incidental diagnostic rate is only about 3% [2].
Despite serotonin can be detected immunohistochemi-
cally in GCC tumor [14], there is no carcinoid syndrome
has been reported in GCC patients and urinary 5-
hydroxyindoleacetic acid (5-HIAA) levels in these pa-
tients are usually within normal limits, as opposed to
carcinoid tumors, which are commonly with elevated
urinary 5-HIAA and serum chromogranin A [15].
The most common route of metastases is trans-
coelomic/peritoneal invasion, and the most common
sites involved are ovaries, and the peritoneal surfaces of
the pelvis and abdominal cavity [10].
The natural history of patients with GCC is intermedi-
ate in aggressiveness between adenocarcinomas and
classical carcinoids [10]. Based on its natural history and
malignant nature, optimal therapeutic startegies are in
general similar to adenocarcinomas rather than classical
carcinoids [10]. Thus, surgical management with right
hemicolectomy is recommended after appendectomy for
most cases, particularly those with an adenocarcinoma
components [2]. Nevertheless, right hemicolectomy is a
significant abdominal procedure with an associated risk,
especially in the infirm or elderly [15]. Peritoneal carcin-
omatosis is the most common cause of death [10]. Gob-
let cell carcinooids are associated with a 60% 10-year
survival and is similar to survival after treatment of a
low-risk adenocarcinoma [15]. The prognosis of GCC is
intermediate between appendiceal carcinoids and adeno-
carcinomas [10].
Our patient, who experienced abdominal pain inter-
mittently for months had been diagnosed with periton-
itis related to peritoneal dialysis. Given a clinical history
of recurrent sterile peritonitis with a predominance of
lymphocytes in the dialysate, an atypical infection (in-
cluding tuberculosis) and intra-abdominal malignancy
must be considered in the differential diagnosis. How-
ever, no dialysate or ascites was sent to cytology analysis
in our patient. We also considered intermittent bowel
obstruction as the cause of abdominal pain, which was
the common presentation of GCC [1], but there were no
sufficient evidence to support the possibility.
Of all the carcinoid tumors, GCC, in particular, can
initially present with acute appendicitis, chronic inter-
mittent abdominal pain, and malignant ascites mim-
icking peritonitis related to peritoneal dialysis in such
patient. Through systematic review of PubMed and
Cochrane Library databases, there were no similar
cases reported. We report this unique case of GCC
presenting with sterile peritonitis in a patient on peri-
toneal dialysis to prompt clinicians to consider GCC
in the differential diagnosis of similar symptoms in
such patients.
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Fig. 2 Peritoneum obtained by laparotomy. (200X) a H & E staining
shows typical goblet cell carcinoid. The photomicrography shows
goblet cell carcinoid composed of concentric infiltrating neoplastic
cells in the appendiceal wall, including the mucosa, submucosa,
muscular propria, and subserosal layers. The infiltrated wall shows
fibrotic change. The tumor includes small solid or tubule-like tumor
clusters, displaying monotonous nuclei with fine chromatin and
eosinophilic cytoplasm, and occasional mucin-producing goblet cells
arranged singly or small nests. b The Immunohistochemical study is
positive for chromogranin A Brown color (arrow)
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